| 1 | Critical Care: A Special Issue of the Blue Journal | 9.7 | 0 | Citations (PDF) |
| 2 | A Lipid Map for Community-acquired Pneumonia with Sepsis: Observation Is the First Step in Scientific Progress | 9.7 | 1 | Citations (PDF) |
| 3 | From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU | 9.7 | 13 | Citations (PDF) |
| 4 | Early Mortality in Clinical Trials of Acute Respiratory Distress Syndrome | 9.7 | 2 | Citations (PDF) |
| 5 | Nonparametric Causal Effects Based on Longitudinal Modified Treatment Policies | 3.5 | 41 | Citations (PDF) |
| 6 | Influence of social deprivation index on in-hospital outcomes of COVID-19 | 3.7 | 6 | Citations (PDF) |
| 7 | Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative | 14.1 | 24 | Citations (PDF) |
| 8 | Kidney Recovery and Death in Critically Ill Patients With COVID-19–Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study | 5.6 | 29 | Citations (PDF) |
| 9 | Transesophageal echocardiography and risk of respiratory failure in patients who had ischemic stroke or transient ischemic attack: an IDEAL phase 4 study | 1.2 | 3 | Citations (PDF) |
| 10 | Prolonged Unconsciousness is Common in COVID‐19 and Associated with Hypoxemia | 6.6 | 18 | Citations (PDF) |
| 11 | Post–Intensive Care Unit Syndrome in a Cohort of COVID-19 Survivors in New York City | 3.8 | 38 | Citations (PDF) |
| 12 | Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19 | 2.4 | 9 | Citations (PDF) |
| 13 | Rapidly improving acute respiratory distress syndrome in COVID-19: a multi-centre observational study | 4.4 | 9 | Citations (PDF) |
| 14 | Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome | 3.6 | 20 | Citations (PDF) |
| 15 | Assessing mortality differences across acute respiratory failure management strategies in Covid-19 | 2.3 | 6 | Citations (PDF) |
| 16 | Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19 | 3.8 | 10 | Citations (PDF) |
| 17 | Patient care in rapid-expansion intensive care units during the COVID-19 pandemic crisis | 2.3 | 6 | Citations (PDF) |
| 18 | Sepsis subphenotyping based on organ dysfunction trajectory | 6.9 | 35 | Citations (PDF) |
| 19 | A metagenomic DNA sequencing assay that is robust against environmental DNA contamination | 14.1 | 14 | Citations (PDF) |
| 20 | Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes | 25.6 | 97 | Citations (PDF) |
| 21 | Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 | 8.9 | 377 | Citations (PDF) |
| 22 | AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19 | 0.4 | 210 | Citations (PDF) |
| 23 | Decreased IDO1-dependent tryptophan metabolism in aged lung during influenza | 7.7 | 9 | Citations (PDF) |
| 24 | Peritraumatic Stress Symptoms during Early Post–Intensive Care Unit Recovery | 3.8 | 0 | Citations (PDF) |
| 25 | Effect of Neutropenic Critical Illness on Development and Prognosis of Acute Respiratory Distress Syndrome | 9.7 | 11 | Citations (PDF) |
| 26 | Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019–Related Respiratory Failure* | 0.6 | 76 | Citations (PDF) |
| 27 | Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions | 14.1 | 118 | Citations (PDF) |
| 28 | A Comparative Analysis of the Respiratory Subscore of the Sequential Organ Failure Assessment Scoring System | 3.8 | 10 | Citations (PDF) |
| 29 | Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation | 4.8 | 19 | Citations (PDF) |
| 30 | Update in Critical Care 2020 | 9.7 | 0 | Citations (PDF) |
| 31 | Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19 | 10.5 | 87 | Citations (PDF) |
| 32 | Critical carE Database for Advanced Research (CEDAR): An automated method to support intensive care units with electronic health record data | 4.8 | 21 | Citations (PDF) |
| 33 | Cytokine signatures of end organ injury in COVID-19 | 3.7 | 30 | Citations (PDF) |
| 34 | Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health | 13.3 | 22 | Citations (PDF) |
| 35 | Hospital-Level Variation in Death for Critically Ill Patients with COVID-19 | 9.7 | 40 | Citations (PDF) |
| 36 | Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19 | 3.7 | 21 | Citations (PDF) |
| 37 | Association of body mass index with morbidity in patients hospitalised with COVID-19 | 2.6 | 5 | Citations (PDF) |
| 38 | Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID‐19 in the US | 4.3 | 15 | Citations (PDF) |
| 39 | Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 | 26.3 | 145 | Citations (PDF) |
| 40 | Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19Chest, 2021, 160, 929-943 | 0.5 | 28 | Citations (PDF) |
| 41 | Percutaneous and Open Tracheostomy in Patients with COVID-19 | 4.9 | 35 | Citations (PDF) |
| 42 | Evaluation of Albumin Kinetics in Critically Ill Patients With Coronavirus Disease 2019 Compared to Those With Sepsis-Induced Acute Respiratory Distress Syndrome 2021, 3, e0589 | | 8 | Citations (PDF) |
| 43 | Heart rate variability measures for prediction of severity of illness and poor outcome in ED patients with sepsis | 1.6 | 19 | Citations (PDF) |
| 44 | Aortic Rupture as a Complication of Cardiopulmonary Resuscitation | 0.5 | 0 | Citations (PDF) |
| 45 | Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US | 8.9 | 686 | Citations (PDF) |
| 46 | Obesity and COVID-19 in New York City: A Retrospective Cohort Study | 10.5 | 67 | Citations (PDF) |
| 47 | Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19 | 2.2 | 98 | Citations (PDF) |
| 48 | Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease | 2.5 | 16 | Citations (PDF) |
| 49 | Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States | 5.3 | 90 | Citations (PDF) |
| 50 | Respiratory Mechanics and Gas Exchange in COVID-19–associated Respiratory Failure | 3.8 | 102 | Citations (PDF) |
| 51 | Letter from the United States | 3.8 | 3 | Citations (PDF) |
| 52 | Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza | 14.3 | 508 | Citations (PDF) |
| 53 | Peritraumatic Stress among Caregivers of Patients in the Intensive Care Unit | 3.8 | 10 | Citations (PDF) |
| 54 | Persistent severe acute respiratory distress syndrome for the prognostic enrichment of trials | 2.5 | 11 | Citations (PDF) |
| 55 | Clinical Characteristics of Covid-19 in New York City | 25.5 | 1,696 | Citations (PDF) |
| 56 | Circulating Mitochondrial DNA as Predictor of Mortality in Critically Ill PatientsChest, 2019, 156, 1120-1136 | 0.5 | 39 | Citations (PDF) |
| 57 | Rapidly Improving ARDS in Therapeutic Randomized Controlled TrialsChest, 2019, 155, 474-482 | 0.5 | 69 | Citations (PDF) |
| 58 | Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis | 5.5 | 36 | Citations (PDF) |
| 59 | Circulating RIPK3 levels are associated with mortality and organ failure during critical illness | 5.5 | 30 | Citations (PDF) |
| 60 | Danger Signals in the ICU | 0.6 | 18 | Citations (PDF) |
| 61 | The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness | 9.7 | 35 | Citations (PDF) |
| 62 | Response | 2.3 | 0 | Citations (PDF) |
| 63 | Oxygen at Risk | 3.8 | 1 | Citations (PDF) |
| 64 | Acute respiratory distress syndrome without identifiable risk factors: A secondary analysis of the ARDS network trials | 2.3 | 13 | Citations (PDF) |
| 65 | RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury | 5.5 | 60 | Citations (PDF) |
| 66 | Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit | 6.9 | 171 | Citations (PDF) |
| 67 | A Technique of Awake Bronchoscopic Endotracheal Intubation for Respiratory Failure in Patients With Right Heart Failure and Pulmonary Hypertension | 0.6 | 27 | Citations (PDF) |
| 68 | Bronchoscopic intubation is an effective airway strategy in critically ill patients | 2.3 | 12 | Citations (PDF) |
| 69 | The authors reply | 0.6 | 0 | Citations (PDF) |
| 70 | Ultrasound in the diagnosis and management of pneumonia | 3.5 | 10 | Citations (PDF) |
| 71 | Validation of the Recently Proposed qSOFA Score in the Weill Cornell Medicine Registry of Critical Illness | 0.5 | 1 | Citations (PDF) |
| 72 | LATE-BREAKING ABSTRACT: Plasma level of TRAIL is associated with severity of sepsis and predicts survival after critical illness 2016, , OA3021 | | 0 | Citations (PDF) |
| 73 | Severe Cavitary, Fistulating <i>Mycobacterium avium–intracellulare</i> Complex Disease in an Immunocompetent Host | 9.7 | 3 | Citations (PDF) |
| 74 | Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control study | 2.0 | 20 | Citations (PDF) |
| 75 | One airway: Biomarkers of protection from upper and lower airway injury after World Trade Center exposure | 2.8 | 14 | Citations (PDF) |
| 76 | Chitotriosidase is a Biomarker for the Resistance to World Trade Center Lung Injury in New York City Firefighters | 3.4 | 21 | Citations (PDF) |
